Pharmaceutical company focused on developing oral and mucosal delivery of injectable drugs and vaccines. Features company profile, products, careers and contacts.
http://www.dorbiopharma.com/

DOR BioPharma, Inc. ( DOR ) is a biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious ...
http://www.dorbiopharma.com/index.html

Get detailed information on DOR BIOPHARMA INC (DORB.OB) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest ...
http://finance.yahoo.com/q?s=dorb.ob

Enter your Email for a Free Trial:
http://www.edgar-online.com/brand/yahoo/search/?cik=812796

Capabilities and Services. Molecular Biology. Expression Technologies; Pf?nex Expression ... DOR BioPharma and Dowpharma SM Complete Feasibility Study for Production of BT-VACC ...
http://pharma.dow.com/pharma/biopharma/news/20051117a.htm

DOR BioPharma, Inc. (OTCBB: DORB , a biopharmaceutical firm, said today it has launched a drug-supply program in Latin America aimed at patients suffering from acute ...
http://www.njbiz.com/article.asp?aID=75822

Capabilities and Services. Molecular Biology. Expression Technologies; Pf?nex Expression ... DOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin
http://pharma.dow.com/pharma/biopharma/news/20030314a.htm

DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company") today announced its financial results for the second quarter ended June 30, 2008. Revenues for the second quarter of 2008 ...
http://money.cnn.com/news/newsfeeds/articles/marketwire/0425456.htm

Get the latest on DOR BioPharma, Inc. (DORB) including up to date news, high quality discussion groups and more on Google Finance.
http://finance.google.com/finance?q=OTC:DORB

MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products.
http://www.marketwatch.com/tools/quotes/profile.asp?symb=DORB&sid=957294&dist=TQP_Nav_profile

doa.de: dor biopharma: 0.08: stock: ger: doa.f: dor biopharma: 0.07: stock: fra: doa.mu: dor biopharma: 0.05: stock: mun: doa.sg: dor biopharma: 0.03: stock: stu: doa.be: dor biopharma: 0.07: stock: ber
http://finance.yahoo.com/q?s=dor&d=t

DOR BioPharma Forms orBec(R) European Medical Advisory Board. - EWING, NJ--(MARKET WIRE)--Sep 17, 2008 -- DOR BioPharma, Inc. (DOR or the Company) (OTC BB:DORB.
http://ca.us.biz.yahoo.com/iw/080917/0434429.html

MIAMI--(BUSINESS WIRE)--Feb. 4, 2004--In response to recent events and queries received from the investing public, DOR BioPharma, Inc. ("DOR" or "the Company") (AMEX:DOR) is
http://www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20040204005370&newsLang=en

DOR BioPharma Announces Named Patient Access Program for orBec(R) in Singapore and Malaysia in Collaboration With Steward Cross Pte Ltd
http://money.cnn.com/news/newsfeeds/articles/marketwire/0417024.htm

DOR BioPharma Reports 2nd Quarter 2008 Financial Results. - EWING, NJ--(MARKET WIRE)--Aug 15, 2008 -- DOR BioPharma, Inc. (OTC BB:DORB.
http://au.us.biz.yahoo.com/iw/080815/0425456.html

DOR BioPharma, Inc. (OTCBB: DORB), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious ...
http://www.medicalnewstoday.com/articles/108845.php

DOR BioPharma, Inc. (OTCBB: DORB) (DOR or The Company), a late-stage biopharmaceutical company, announced the initiation of a comprehensive program to evaluate the efficacy of ...
http://www.medicalnewstoday.com/articles/105709.php

DOR BioPharma Reports 1st Quarter 2008 Financial Results. - EWING, NJ--(MARKET WIRE)--May 16, 2008 -- DOR BioPharma, Inc. (OTC BB:DORB.
http://au.us.biz.yahoo.com/iw/080516/0398053.html

DOR BioPharma (DOR) stock profile information from InvestorWords - The Most Comprehensive Investing Glossary on the Web! Over 6000 financial and investing definitions, with links ...
http://www.investorwords.com/cgi-bin/stocksymbol.cgi?ticker=DOR

MIAMI--(BUSINESS WIRE)--Aug. 30, 2006--DOR BioPharma, Inc. (OTCBB:DORB) ("DOR" or the "Company"), a biopharmaceutical company addressing life-threatening side effects of cancer and
http://www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060830005639&newsLang=en